CIA
TWST icon

Concurrent Investment Advisors’s Twist Bioscience TWST Stock Holding History

Concurrent Investment Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,178
Closed -$375K – 999
2023
Q4 		$375K Buy
+10,178
New +$235K 0.02% 572

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Concurrent Investment Advisors's TWST Position: Q1 2024 in Review

Concurrent Investment Advisors sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 10,178 shares — an estimated $375K sold.

Concurrent Investment Advisors first reported a position in TWST in Q4 2023 and held it in 1 quarter. The position peaked at $375K in Q4 2023. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

  • Concurrent Investment Advisors reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
  • Concurrent Investment Advisors sold 10,178 Twist Bioscience shares in Q1 2024, an estimated $375K.
  • Concurrent Investment Advisors first reported a position in Twist Bioscience in Q4 2023 and held it in 1 quarter.
  • Concurrent Investment Advisors's Twist Bioscience position peaked at $375K in Q4 2023.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Concurrent Investment Advisors's 13F filing for Q1 2024, filed 7 May 2024.